DOV Pharmaceutical INC
SEC CIK 1066833 · DVOP · last insider filing 2008-11-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Zakrzewski Joseph S | Director | filed 2008 - 2008 |
| Horovitz Zola P | Director | filed 2006 - 2008 |
| VAN Riper Daniel S | Director | filed 2006 - 2008 |
| Podlesak Dennis | Director | filed 2006 - 2008 |
| Duncan Barbara Gayle | Director · President and CFO | filed 2006 - 2008 |
| Lippa Arnold | Director | filed 2007 - 2008 |
| Ashe Patrick | Director | filed 2006 - 2008 |
| DOV Pharmaceutical INC | Director · Sr. V.P. Research, CSO | filed 2006 - 2008 |
| Isaly Samuel D | Director | filed 2006 - 2006 |
| Orbimed Advisors LLC | Director | filed 2006 - 2006 |
| Orbimed Capital LLC | Director | filed 2006 - 2006 |
| Hudson Leslie | Director · CEO and President | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Skolnick Phil | Sr. V.P. Research, CSO | filed 2006 - 2008 |
| Stern Warren Charles | Sr. V.P. Drug Development | filed 2006 - 2007 |
| Myers Scott Dunseth | Senior Vice President | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.